Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples